CIDRAP newsletters options
Uganda (191% rise in cases), Colombia (40%), Malaysia (38%), and Bahrain (32%) are getting hit hard.
More than two thirds of antibiotics prescribed for respiratory tract infections at primary care practices within an academic health system were inappropriate, with unnecessary prescribing strongly linked to respiratory infections that almost never require antibiotics, researchers reported today in Infection Control & Hospital Epidemiology.
Prophylactic hydroxychloroquine treatment was not associated with any risk difference for COVID-19 infection, according to an International Journal of Infectious Diseases study yesterday.
WHO advisors have approved emergency listing for China's two-dose vaccine.
IQVIA's 5-year forecast estimates the pandemic's effects on the global pharmaceutical market.
About 90% of cancer patients had adequate coronavirus antibodies after vaccination.
Thirty-seven million Americans planned to travel 50 or more miles over the weekend, up 14 million from last year.
COVID-19 infection was 94% less likely in people previously infected than in those never infected, according to a research letter late last week in JAMA Internal Medicine. However, the researchers note, their study concluded before COVID-19 variants became dominant.
CARB-X announced today that it is awarding Swiss pharmaceutical company BioVersys up to $4.35 million to develop a new class of antibiotics to treat life-threatening infections caused by multidrug-resistant bacteria.
"Our study does not necessarily mean that all mass events are safe."
The drop in cases has been slow in the Tokyo area, which will host the Olympics in late July.
In a new poll, 62% of US adults saying they've gotten at least one dose, up from 56% in April.
The Global Antibiotic Research and Development Partnership (GARDP), on behalf of the Drugs for Neglected Diseases initiative, issued a statement this week that called on World Health Organization (WHO) member states to strengthen their responses to antimicrobial resistance (AMR).
Hospitalization, hypoxemia, pneumonia, and other complications were found more in children who contracted COVID-19 than in those who had seasonal flu, according to a study today in Pediatrics.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Also, Japanese officials are mulling extending the state of emergency for much of the country.
In the US, overdose-related cardiac deaths rose 42%, and in Ontario, opioid deaths climbed 135%.
As vaccinations increase, COVID-19 cases continue to drop across the country.
A randomized controlled trial of two inactivated (vero cell) COVID-19 vaccines made in China finds a vaccine efficacy of 73% in one and 78% in the other, according to a study yesterday in JAMA.
The whole-virus inactivated vaccines were developed with strains of the virus taken from patients in Wuhan, China.
CARB-X announced today that it is awarding up to $3.9 million to a Danish microbiome biotechnology company to develop a CRISPR-based drug to prevent Escherichia coli infections in cancer patients.
